0.3608
price down icon11.59%   -0.0473
 
loading

Cellectar Biosciences Inc Stock (CLRB) Forecast

The Cellectar Biosciences Inc (CLRB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.505, representing a +594.28% increase from the current price of $0.3608. The highest analyst price target is $3.1426, and the lowest is $1.8674.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLRB Price Target
Average 8.8432 (+2,351% Upside)
loading

Is Cellectar Biosciences Inc (CLRB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 59.91 Neutral
STOCH(9,6) 49.17 Neutral
STOCHRSI(14) 44.16 Neutral
MACD(12,26) 0.0236 Buy
ADX(14) 28.31 Buy
William %R -72.96 Neutral
CCI(14) 141.38 Buy
Buy: 3 Sell: 0 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.3037
Buy
0.3247
Buy
MA20
0.2774
Buy
0.2983
Buy
MA50
0.2814
Buy
0.3002
Buy
MA100
0.2894
Buy
0.447
Sell
MA200
0.9534
Sell
0.9789
Sell
Buy: 7 Sell: 3 Neutral: 0
Summary: Buy
According to our latest analysis, CLRB could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 3 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on CLRB, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 59.91 indicates that CLRB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 49.17 indicates that CLRB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.16 indicates that CLRB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 28.31 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 141.38 indicates that CLRB is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term CLRB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Cellectar Biosciences Inc financial reports and earnings history, Cellectar Biosciences Inc (CLRB) stock could reach $17.46 by 2030, $17.60 by 2040 and $45.19 by 2050. See the projected annual prices until 2050 of the Cellectar Biosciences Inc stock below:

  • Cellectar Biosciences Inc (CLRB) is expected to reach an average price of $6.4762 in 2035, with a high prediction of $6.5486 and a low estimate of $6.5462. This indicates an $1,695% rise from the last recorded price of $0.3608.
  • Cellectar Biosciences Inc (CLRB) stock is projected to chart a bullish course in 2040, with an average price target of $17.06, representing an $4,628% surge from its current level. The forecast ranges from a conservative $17.18 to a sky-high $17.60.
  • Our analysts predict Cellectar Biosciences Inc (CLRB) to jump 7,901% by 2045, soaring from $28.34 to an average price of $28.87, potentially reaching $28.52. While $28.34 is the low estimate, the potential upside is significant.
  • Cellectar Biosciences Inc (CLRB) stock is expected to climb by 2050, reaching an average of $44.15, a $12,135% jump from its current level. However, a wide range of estimates exists, with high and low targets of $45.19 and $45.05, respectively, highlighting the market's uncertainty.

Cellectar Biosciences Inc Stock (CLRB) Year by Year Forecast

Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2025

Cellectar Biosciences Inc Stock (CLRB) is expected to reach an average price of $8.2588 in 2025, with a high prediction of $16.40 and a low estimate of $0.1202. This indicates an +2,189% rise from the last recorded price of $0.3608.
Month Average Low High Change from today's price
July, 2025 $3.3426 $1.8674 $3.1426 +826.43%
August, 2025 $0.5177 $1.7177 $2.1301 +43.49%
September, 2025 $1.2919 $1.3929 $2.0509 +258.06%
October, 2025 $4.1118 $2.1367 $3.0118 +1,040%
November, 2025 $2.287 $2.987 $2.3556 +533.86%
December, 2025 $3.0059 $2.5183 $1.9308 +733.13%

Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2026

The predicted value for Cellectar Biosciences Inc (CLRB) in 2026 is set at an average of $8.2274. Estimates vary from a peak of $16.29 to a trough of $0.1614, indicating an +2,180% surge from the present price of $0.3608.
Month Average Low High Change from today's price
January, 2026 $1.8811 $2.3771 $2.4373 +421.37%
February, 2026 $8.3438 $1.9249 $10.63 +2,213%
March, 2026 $6.4686 $4.10 $15.60 +1,693%
April, 2026 $11.55 $2.889 $16.29 +3,101%
May, 2026 $5.5745 $2.4621 $11.41 +1,445%
June, 2026 $1.7993 $1.4869 $5.9307 +398.70%
July, 2026 $0.1804 $0.4196 $4.0242 -50.01%
August, 2026 $1.6052 $0.2366 $5.849 +344.91%
September, 2026 $0.5137 $0.1614 $1.8114 +42.39%
October, 2026 $1.7889 $1.5451 $0.9889 +395.81%
November, 2026 $1.564 $2.264 $2.5765 +333.49%
December, 2026 $2.333 $1.6078 $1.483 +546.62%

Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Cellectar Biosciences Inc (CLRB) is $3.7463, with a high forecast of $4.963 and a low forecast of $2.5295. This indicates an +938.32% increase from the last price of $0.3608.
Month Average Low High Change from today's price
January, 2027 $2.2632 $2.5432 $2.2268 +527.26%
February, 2027 $3.4833 $2.5295 $2.2353 +865.44%
March, 2027 $3.8523 $4.0311 $3.8647 +967.70%
April, 2027 $3.5384 $3.9774 $3.6961 +880.72%
May, 2027 $4.5996 $4.7578 $4.0438 +1,175%
June, 2027 $5.3315 $4.9464 $4.8777 +1,378%
July, 2027 $2.9187 $3.1967 $4.7653 +708.95%
August, 2027 $3.6509 $3.1405 $2.6749 +911.88%
September, 2027 $4.8918 $4.5456 $4.963 +1,256%
October, 2027 $5.236 $5.1784 $4.957 +1,351%
November, 2027 $4.3821 $4.9411 $4.5173 +1,115%
December, 2027 $2.6801 $3.5101 $4.1409 +642.81%

Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2028

In 2028, Cellectar Biosciences Inc (CLRB) is projected to reach an average price of $4.3469, with a high projection of $5.7234 and a low estimate of $2.9704. This indicates an +1,105% rise from the last price of $0.3608.
Month Average Low High Change from today's price
January, 2028 $3.0954 $2.9704 $2.8702 +757.94%
February, 2028 $4.7504 $3.459 $3.9904 +1,217%
March, 2028 $5.8093 $4.7342 $5.6855 +1,510%
April, 2028 $5.6845 $5.8007 $5.7169 +1,476%
May, 2028 $5.7734 $5.7021 $5.7234 +1,500%
June, 2028 $5.5886 $5.4648 $5.5372 +1,449%
July, 2028 $5.1738 $5.2938 $5.4324 +1,334%
August, 2028 $4.9827 $5.0326 $5.0613 +1,281%
September, 2028 $4.9779 $5.0003 $4.9141 +1,280%
October, 2028 $4.683 $4.723 $4.8917 +1,198%
November, 2028 $4.182 $4.312 $4.6068 +1,059%
December, 2028 $3.6871 $3.8371 $3.9558 +921.94%

Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2029

The 2029 price forecast for Cellectar Biosciences Inc Stock (CLRB) is $6.3449 on average, with a high prediction of $12.68 and a low estimate of $0.00979. This represents an +1,659% increase from the previous price of $0.3608.
Month Average Low High Change from today's price
January, 2029 $3.4061 $3.4495 $3.6147 +844.04%
February, 2029 $3.3913 $3.5313 $3.4275 +839.93%
March, 2029 $2.6964 $2.8626 $3.205 +647.34%
April, 2029 $2.0916 $2.1278 $2.1702 +479.70%
May, 2029 $2.4605 $2.0754 $2.0147 +581.96%
June, 2029 $1.6057 $1.7857 $2.2043 +345.03%
July, 2029 $1.1808 $1.4908 $1.4695 +227.28%
August, 2029 $0.2402 $0.00979 $0.7102 -33.42%
September, 2029 $0.1049 $0.0464 $0.3964 -70.91%
October, 2029 $0.8861 $0.0387 $1.1737 +145.59%
November, 2029 $0.0909 $0.0709 $1.0984 -74.79%
December, 2029 $16.08 $0.0592 $12.68 +4,357%

Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2030

Cellectar Biosciences Inc Stock (CLRB) is expected to reach an average price of $14.06 in 2030, with a high forecast of $21.11 and a low forecast of $7.0095. This signifies an +3,796% surge from the last price of $0.3608.
Month Average Low High Change from today's price
January, 2030 $15.72 $17.23 $17.46 +4,256%
February, 2030 $15.87 $16.58 $15.37 +4,298%
March, 2030 $15.47 $15.52 $15.36 +4,187%
April, 2030 $15.47 $15.58 $14.77 +4,187%
May, 2030 $16.01 $13.97 $15.01 +4,337%
June, 2030 $19.93 $18.69 $17.77 +5,424%
July, 2030 $19.79 $20.53 $21.11 +5,386%
August, 2030 $13.65 $14.55 $16.76 +3,682%
September, 2030 $8.2956 $11.45 $10.52 +2,199%
October, 2030 $4.8505 $7.0095 $6.5832 +1,244%
November, 2030 $16.28 $11.42 $11.25 +4,413%
December, 2030 $20.74 $20.15 $18.90 +5,647%
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Cap:     |  Volume (24h):